 |
The Journal of Neuroscience, April 18, 2007, 27(16):4385-4395; doi:10.1523/JNEUROSCI.0055-07.2007
Previous Article | Next Article 
Neurobiology of Disease
Dietary Docosahexaenoic Acid and Docosapentaenoic Acid Ameliorate Amyloid-ß and Tau Pathology via a Mechanism Involving Presenilin 1 Levels
Kim N. Green,1
Hilda Martinez-Coria,1
Hasan Khashwji,1
Eileen B. Hall,2
Karin A. Yurko-Mauro,2
Lorie Ellis,2 and
Frank M. LaFerla1
1Department of Neurobiology and Behavior, University of California, Irvine, California 92697-4545, and 2Martek Biosciences Corporation, Columbia, Maryland 21045
Correspondence should be addressed to Dr. Frank M. LaFerla, Department of Neurobiology and Behavior, University of California, Irvine, 1109 Gillespie Neuroscience Building, Irvine, CA 92697-4545. Email: laferla{at}uci.edu
The underlying cause of sporadic Alzheimer disease (AD) is unknown, but a number of environmental and genetic factors are likely to be involved. One environmental factor that is increasingly being recognized as contributing to brain aging is diet, which has evolved markedly over modern history. Here we show that dietary supplementation with docosahexaenoic acid (DHA), an n-3 polyunsaturated fatty acid, in the 3xTg-AD mouse model of AD reduced the intraneuronal accumulation of both amyloid-ß (Aß) and tau. In contrast, combining DHA with n-6 fatty acids, either arachidonic acid or docosapentaenoic acid (DPAn-6), diminished the efficacy of DHA over a 12 month period. Here we report the novel finding that the mechanism accounting for the reduction in soluble Aß was attributable to a decrease in steady-state levels of presenilin 1, and not to altered processing of the amyloid precursor protein by either the - or ß-secretase. Furthermore, the presence of DPAn-6 in the diet reduced levels of early-stage phospho-tau epitopes, which correlated with a reduction in phosphorylated c-Jun N-terminal kinase, a putative tau kinase. Collectively, these results suggest that DHA and DPAn-6 supplementations could be a beneficial natural therapy for AD.
Key words: tau; Alzheimer's; docosahexanoic acid; docosapentaenoic acid; presenilin; amyloid; transgenic
Received Sept. 20, 2006;
revised Feb. 15, 2007;
accepted March 16, 2007.
Correspondence should be addressed to Dr. Frank M. LaFerla, Department of Neurobiology and Behavior, University of California, Irvine, 1109 Gillespie Neuroscience Building, Irvine, CA 92697-4545. Email: laferla{at}uci.edu
Related articles in J. Neurosci.:
- This Week in The Journal
J. Neurosci. 2007 27: i.
[Full Text]
This article has been cited by other articles:

|
 |

|
 |
 
R. K. McNamara
DHA Deficiency and Prefrontal Cortex Neuropathology in Recurrent Affective Disorders
J. Nutr.,
April 1, 2010;
140(4):
864 - 868.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. M. Cole and S. A. Frautschy
DHA May Prevent Age-Related Dementia
J. Nutr.,
April 1, 2010;
140(4):
869 - 874.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Zhang and N. G. Bazan
Lipid-Mediated Cell Signaling Protects against Injury and Neurodegeneration
J. Nutr.,
April 1, 2010;
140(4):
858 - 863.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. H. Axelsen and R. C. Murphy
Quantitative analysis of phospholipids containing arachidonate and docosahexaenoate chains in microdissected regions of mouse brain
J. Lipid Res.,
March 1, 2010;
51(3):
660 - 671.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Joseph, G. Cole, E. Head, and D. Ingram
Nutrition, Brain Aging, and Neurodegeneration
J. Neurosci.,
October 14, 2009;
29(41):
12795 - 12801.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Q.-L. Ma, F. Yang, E. R. Rosario, O. J. Ubeda, W. Beech, D. J. Gant, P. P. Chen, B. Hudspeth, C. Chen, Y. Zhao, et al.
{beta}-Amyloid Oligomers Induce Phosphorylation of Tau and Inactivation of Insulin Receptor Substrate via c-Jun N-Terminal Kinase Signaling: Suppression by Omega-3 Fatty Acids and Curcumin
J. Neurosci.,
July 15, 2009;
29(28):
9078 - 9089.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. Dangi, M. Obeng, J. M. Nauroth, M. Teymourlouei, M. Needham, K. Raman, and L. M. Arterburn
Biogenic Synthesis, Purification, and Chemical Characterization of Anti-inflammatory Resolvins Derived from Docosapentaenoic Acid (DPAn-6)
J. Biol. Chem.,
May 29, 2009;
284(22):
14744 - 14759.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Holguin, J. Martinez, C. Chow, and R. Wurtman
Dietary uridine enhances the improvement in learning and memory produced by administering DHA to gerbils
FASEB J,
November 1, 2008;
22(11):
3938 - 3946.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Bousquet, M. Saint-Pierre, C. Julien, N. Salem Jr., F. Cicchetti, and F. Calon
Beneficial effects of dietary omega-3 polyunsaturated fatty acid on toxin-induced neuronal degeneration in an animal model of Parkinson's disease
FASEB J,
April 1, 2008;
22(4):
1213 - 1225.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Q.-L. Ma, B. Teter, O. J. Ubeda, T. Morihara, D. Dhoot, M. D. Nyby, M. L. Tuck, S. A. Frautschy, and G. M. Cole
Omega-3 Fatty Acid Docosahexaenoic Acid Increases SorLA/LR11, a Sorting Protein with Reduced Expression in Sporadic Alzheimer's Disease (AD): Relevance to AD Prevention
J. Neurosci.,
December 26, 2007;
27(52):
14299 - 14307.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. D. Stark, S.-Y. Lim, and N. Salem Jr.
Artificial rearing with docosahexaenoic acid and n-6 docosapentaenoic acid alters rat tissue fatty acid composition
J. Lipid Res.,
November 1, 2007;
48(11):
2471 - 2477.
[Abstract]
[Full Text]
[PDF]
|
 |
|
|
|

|